pLX304-IRES-Td
(Plasmid
#176296)
-
Purpose(Empty Backbone) pLX304 backbone with an IRES-Tdtomato cassette subcloned into the NheI-AgeI sites
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 176296 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepLX304
-
Backbone manufacturerNone
- Backbone size (bp) 10000
-
Modifications to backbonean IRES-TdTomato cassette was sub cloned into the NheI-AgeI sites
-
Vector typeMammalian Expression, Lentiviral
- Promoter CMV
-
Selectable markersBlasticidin
-
Tag
/ Fusion Protein
- V5 (C terminal on backbone)
Growth in Bacteria
-
Bacterial Resistance(s)Chloramphenicol and Ampicillin, 25 & 100 μg/mL
-
Growth Temperature30°C
-
Growth Strain(s)ccdB Survival
-
Growth instructionsLonger growth may be needed
-
Copy numberHigh Copy
Cloning Information
- Cloning method Gateway Cloning
- 5′ sequencing primer CMV
- 3′ sequencing primer attB2 (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pLX304-IRES-Td was a gift from William Kaelin (Addgene plasmid # 176296 ; http://n2t.net/addgene:176296 ; RRID:Addgene_176296) -
For your References section:
Targeting oncoproteins with a positive selection assay for protein degraders. Koduri V, Duplaquet L, Lampson BL, Wang AC, Sabet AH, Ishoey M, Paulk J, Teng M, Harris IS, Endress JE, Liu X, Dasilva E, Paulo JA, Briggs KJ, Doench JG, Ott CJ, Zhang T, Donovan KA, Fischer ES, Gygi SP, Gray NS, Bradner J, Medin JA, Buhrlage SJ, Oser MG, Kaelin WG Jr. Sci Adv. 2021 Feb 5;7(6). pii: 7/6/eabd6263. doi: 10.1126/sciadv.abd6263. Print 2021 Feb. 10.1126/sciadv.abd6263 PubMed 33547076